
VCP979 (VCP-979) is a novel селективный малая молекула p38 MAPK ингибитор with a significantly greater affinity for the active form of p38 MAPK, has significant anti-fibrotic effects in vitro and in vivo.
VCP979 (VCP-979) is a novel selective small molecule p38 MAPK inhibitor with a significantly greater affinity for the active form of p38 MAPK, has significant anti-fibrotic effects in vitro and in vivo.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.